Lactation Suppressed Clinical Trial
Official title:
Satisfaction of Patients With the Chosen Method of Inhibition of Lactation: With the Use of Drugs Lowering the Level of Prolactin or Without the Use of Pharmacological Agents in Postnatal Period, Taking Into Account Individual Conditions
The aim of the study is to improve the standard of care in case of the inhibition of
lactation.
The participant qualified for the study will answer the questions contained in the survey.
The patient will have her breast palpated and then will be instructed on the possible options
for the inhibition of lactation. The participant, who decides to inhibit lactation with
medications, will be consulted by a doctor.
Each patient will receive information of the possible ways to relieve the symptoms of
overfilled breast and be able to contact with lactation consultant. The participant will also
receive a card to assess the severity of symptoms in the following days. The investigators
will call the patient between the third and fifth day by phone.
Once again, after 2 weeks from the beginning of the inhibition of lactation in order to ask
questions contained in the survey (the course of the process, problems that occurred and the
level of satisfaction with the chosen method).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03965572 -
Factors and Outcomes Associated With Postpartum Cabergoline Use
|
||
| Enrolling by invitation |
NCT06029673 -
Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
|
Phase 2 | |
| Completed |
NCT05024422 -
Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline
|
N/A | |
| Recruiting |
NCT06123026 -
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
|
Phase 4 | |
| Completed |
NCT04701333 -
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
|
Phase 2 |